Mongrel dogs with ascites created by inferior vena cava ligation were given cephalothin, cephaloridine, cefazolin, and cefamandole to evaluate the effect of protein binding and serum pharrnacokinetics on the distribution of cephalosporins into ascitic fluid. Antibiotics were given intramuscularly (15 mg/kg) every 4 h for a total of eight doses. Antibiotic binding to dog serum and ascitic fluid was measured by ultracentrifugation. Binding of the cephalosporins to dog serum ranged from 31% for cephaloridine to 46% for cephalothin, considerably lower than human serum binding for cefazolin, cephalothin, and cefamandole. Antibiotic binding to ascitic fluid was only slightly lower than that to serum. Ascitic fluid antibiotic concentrations, which approached equilibrium at 16 to 28 h, were significantly higher for cefazolin and cephaloridine than for cephalothin and cefamandole. However, serum concentrations were also higher for cefazolin and cephaloridine, and percent penetration (ratio of serum peak to ascites peak x 100) was not statistically different among the four drugs. Binding of these cephalosporins to extravascular fluid protein was an important factor that determined the total ascitic fluid antibiotic level achieved. A formula utilizing the log mean serum level and binding to serum and extravascular fluid protein was used to accurately predict ascitic fluid drug levels at equilibrium.
Mongrel dogs with ascites created by inferior vena cava ligation were given cephalothin, cephaloridine, cefazolin, and cefamandole to evaluate the effect of protein binding and serum pharrnacokinetics on the distribution of cephalosporins into ascitic fluid. Antibiotics were given intramuscularly (15 mg/kg) every 4 h for a total of eight doses. Antibiotic binding to dog serum and ascitic fluid was measured by ultracentrifugation. Binding of the cephalosporins to dog serum ranged from 31% for cephaloridine to 46% for cephalothin, considerably lower than human serum binding for cefazolin, cephalothin, and cefamandole. Antibiotic binding to ascitic fluid was only slightly lower than that to serum. Ascitic fluid antibiotic concentrations, which approached equilibrium at 16 to 28 h, were significantly higher for cefazolin and cephaloridine than for cephalothin and cefamandole. However, serum concentrations were also higher for cefazolin and cephaloridine, and percent penetration (ratio of serum peak to ascites peak x 100) was not statistically different among the four drugs. Binding of these cephalosporins to extravascular fluid protein was an important factor that determined the total ascitic fluid antibiotic level achieved. A formula utilizing the log mean serum level and binding to serum and extravascular fluid protein was used to accurately predict ascitic fluid drug levels at equilibrium.
We have previously measured ascitic fluid concentrations of three cephalosporins in a dog model after a single parenteral dose (6) . In this paper we extend these observations to include cefamandole in addition to cefazolin, cephaloridine, and cephalothin in a multiple-dose study of serum and ascitic fluid pharmacokinetics and protein binding of cephalosporins in dogs. The importance of both the log mean serum concentration and protein binding (to ascites and serum) as determinants of the ascitic fluid antibiotic concentration at equilibrium is emphasized.
(This work was presented in part at the 16th Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Ill., 27-29 October 1976.)
MATERIALS AND METHODS Animal model. Ascites was produced in mongrel dogs (initial weight, 14 to 18 kg) by partial ligation of the inferior vena cava as previously described (6) . Dietary sodium chloride supplementation (15 g/day) was required in one dog to maintain ascites. A total of five dogs were used in this study. Ascitic fluid volume was measured each time antibiotics were given, using "2I-labeled human serum albumin (6, 10) . Ascites volumes in a single dog showed variation of from 1.2 to 3.7 liters during the course of the study. Total protein, albumin, creatinine, blood urea nitrogen, bilirubin, serum glutamic oxalacetic tr m , and alkaline phosphatase were determined using the AutoAnalyzer (Technicon, Terrytown, N.Y.). Cell counts were done on a Coulter Counter (Coulter Electronics, Inc., Hialeah, Fla.), and differential cell counts were manually performed.
Antibiotic administration. All cephalosporins were administered at a dose of 15 mg/kg (dry weight prior to ascites) by deep intramuscular injection in the gluteus or quadriceps muscles. Ascitic fluid specimens were obtained by midline abdominal paracentesis, and jugular venipuncture was used to obtain blood. Cefamandole was studied in three dogs after single-dose administration, and cefamandole, cefazolin, cephalothin, and cephaloridine were studied in three dogs after multiple doses. In the single-dose study of cefamandole, serum and ascites specimens were obtained at 0, 0.25, 0.5, 1 through 6, and 24 h after administration. In multiple-dose studies, serum and ascites were obtained 20 min and 4 h after each dose. Each dog was given eight injections on a 4-h schedule for a total study time of 32 h. The entire multidose study was completed during a 3-week period, rotating animals so that a minimum of 7 days and a mimum of 15 Protein binding. Antibiotic binding to both serum and ascitic fluid was determined by an ultracentrifugation method (15) . A minimum of three determinations in ascitic fluid and serum were performed for each antibiotic. Most of the binding determinations were performed in vitro by adding known amounts of drug to pooled ascites or serum; however, in vivo determinations were also performed on specimens obtained from single animals during multidose studies. Both in vivo and in vitro binding was performed for aU antibiotics except cephaloridine (serum), with from one to three in vivo determinations in both serum and ascites for each drug.
Prediction of ascitic fluid concentration. Halflife (tj) in serum was determined from the slope of the least-squares regression line (7) . Log mean serum level (the antibiotic concentration which must be maintained by constant infusion to give the same area under the curve obtained by intermittent administration) was determined by graphically finding the midpoint of a straight line connecting the mean serum peak and trough on semilogarithmic paper. Prediction of antibiotic concentration in ascitic fluid is based on the assumption that unbound antibiotic duses freely between serum and ascites and has the same concentration in both at equilibrium. log mean total serum concentration, F. = free fraction of drug in serum (percent free in serum/100), and F. = free fraction of drug in ascitic fluid (percent free in ascitic fluid/100). From this formula it can be seen that if a drug is bound equaly to serum and ascites, F, is equal to F. and the ascitic fluid level is equal to the log mean serum level.
Statistics. Standard error of the mean was determined by the method of Mantel (11) . Statistical significance was determined by using the Mann-Whitney U test (1) .
RESULTS
Characteristics of ascitic fluid and serum. Ascites and serum cell count, pH, protein, and albumin are shown in Table 1 for four of the five dogs used in this study and did not differ appreciably from values previously reported (6 fluid albumin and 3.1 ug/ml), in the single-dose study (6) .
Percent penetration (ratio of ascites peak to ults of single-serum peak x 100) of cefamandole (9%) was also Laloridine, and significantly less than for cefazolin (25.8%) and been reported cephaloridine (19.1%) (P < 0.05), but not cephs levels after a alothin (21.4%). Mean ascites volume (4.0 liters) hown in Fig. 1 . in the cefamandole studies was lower than in the k ascites levels single-dose studies of the other cephalosporins /ml) were sig-(5.1 to 6.2 liters) and should not have been those of cefa-responsible for the low ascites levels of cefaman-L cephaloridine dole (6).
phalothin (14.5 Results of multiple-dose studies are shown in Fig. 2 . Serun peak concentrations showed some variation, probably as a result of obtaining only a single serum sample 20 min after intramuscular injection. Ascitic fluid levels rose slowly, ME reaching a plateau at 16 to 28 h in most animals.
In dogs with low ascites volumes equilibrium was achieved as early as 8 h. Peak and trough serum concentrations of cefazolin and cephaloridine were higher than for cephalothin and cefamandole and resulted in significantly higher ascites levels at equilibrium (P < 0.05). 5 
X
Mean ascites peak level in the multiple-dose study was (20) . Similarly, cefamandole binding to human serum (80%) is approximately twice as high as in dogs (15, 18) . Canine serum binding of cephaloridine (31%) in this study was higher than previously reported in dogs (10%), but cephalothin binding (46%) agreed with previous reports (13, 20) , although it was considerably lower than the 79% reported in humans (13, 15) . Thus, for three of the four cephalosporins studied in these canine experiments, serum protein binding was markedly lower than in humans, and therefore an inhibitory effect of high serum protein binding on extravascular distribution should not be expected in dogs.
The second variable that serves to explain high extravascular levels of highly bound antibiotics is binding to extravascular fluid protein.
Our measurements in dogs (Table 2) show that cephalosporins are bound only slightly less to ascitic fluid than to serum proteins. This appreciable binding of cephalosporins to ascitic fluid serves to explain why total concentrations of these drugs in ascitic fluid may be quite high. Although free (unbound) drug levels may be relatively low in ascitic fluid, the total drug concentration (bound and unbound) may be very high if large amounts are bound to the protein in the extravascular fluid. Unfortunately, both the factor of lowered serum protein binding and the factor ofsubstantial extravascular binding are operative in the dog model, making it impossible to discern the relative importance of each. However, in humans, where cefazolin serum binding is high, high binding to extravascular fluid protein is very likely the explanation for reported high cefazolin concentrations in ascitic fluid and pleural fluid (3, 4) . In contrast, saline-filled skin windows which contain low amounts of protein also have very low total concentrations of cefazolin, nearly all of which is probably free drug (17) .
It is also clear from our data that cephalosporin serum kinetics (peak and trough levels, tO) in dogs are the major determinant of the equilibrium level achieved in ascitic fluid. The low serum peak levels and short ti of cefamandole and cephalothin, compared to cephaloridine and cefazolin, resulted in markedly lower log mean serum levels of the former drugs when given every 4 h ( Table 4) .
Equation 1 was developed to incorporate the effects of both serum kinetics and protein binding on extravascular penetrance of antibiotics. It is based on the assumption that unbound antibiotic diffuses freely into extravascular body fluids but is bound to these extravascular fluids in proportion to the amount ofprotein (albumin) present in the fluid. The equilibrium level of drug achieved in ascitic fluid is then determined by only two factors, the drug level maintained in the serum (log mean serum level) and the relative binding of the drug to serum and ascitic fluid (ratio of free drug fraction in serum to free drug fraction in ascites). We emphasize that the equation applies only to steady-state or equilibrium conditions. This is particularly important when working with a large extravascular volume such as ascites, in which equilibrium may not occur until multiple doses of drug have been given (Fig. 2) .
Although equation 1 gave a reasonably close prediction of ascites levels, it was about 10% high for cefamandole, cephalothin, and cefazolin and 25% high for cephaloridine (Table 4 ). These small errors may be due to the inherent inaccuracies of the bioassay technique used in determining antibiotic levels and protein binding, or to failure to obtain peak levels in ascitic fluid which may occur at some time between the 20-min and 4-h sampling times used in this study (6) .
In addition to ascites, we expect equation 1 to be applicable to any extravascular fluid into which antibiotic can diffuse freely, such as pleural effusions, joint effusions, and serous wound exudates. A previous study of penicillins in dog ascites has shown good predictability of equation 1 for that class of antibiotics, several of which are highly protein bound (D. N. Gerding, L. R. Peterson, J. K. Salomonson, W. H. Hall, and E. A. Schierl, J. Infect. Dis., in press). It may seem paradoxical that very highly proteinbound drugs actually have the potential to achieve the highest extravascular fluid concentrations due to binding to protein in the extravascular fluid. Of course the free drug concentration of these highly bound drugs will still be low, but as long as it exceeds the minimum inhibitory concentration of susceptible organisms, the drug should be effective. There may even be some advantage in having large amounts of locally bound antibiotic in dynamic equilibrium with free drug at the site of infection, for the protein-bound drug may act as a reservoir to maintain adequate local free drug levels during periods when serum free drug levels are lower than extravascular fluid free drug concentrations.
